Open AccessP135 (0160) BRENTUXIMAB‐VEDOTIN + BENDAMUSTINE: A HIGHLY EFFECTIVE SALVAGE TREATMENT UN REFRACTORY/RELAPSED PATIENTS WITH HODGKIN LYMPHOMA
Publication year - 2018
Publication title -
hemasphere
Language(s) - Uncategorized
Resource type - Journals
SCImago Journal Rank - 0.677
H-Index - 11
ISSN - 2572-9241
DOI - 10.1097/01.hs9.0000547978.61156.2d
Subject(s) - brentuximab vedotin , bendamustine , medicine , salvage therapy , refractory (planetary science) , oncology , lymphoma , chemotherapy , hodgkin lymphoma , rituximab , materials science , composite material